Sam Altman on artificial superintelligence: 'There is a lot of compounding left to do'

Full Article
Sam Altman on artificial superintelligence: 'There is a lot of compounding left to do'

Sam Altman, CEO of OpenAI, discussed the future of Artificial Superintelligence (ASI) in an interview with Garry Tan, CEO of Y Combinator. He emphasized that ASI is still thousands of days away, highlighting the significant progress yet to be made. Altman expressed optimism about the compounding advancements in AI technology over the next few years.

During the conversation, Altman acknowledged potential challenges but maintained a positive outlook on AI's transformative potential for humanity. He reflected on OpenAI's journey since its inception in 2015, noting the strategic focus that has defined the company's approach amidst competition from other AI leaders like DeepMind.

• Altman believes ASI is thousands of days away from realization.

• OpenAI's strategic focus has been crucial in its development journey.

Key AI Terms Mentioned in this Article

Artificial Superintelligence (ASI)

ASI refers to AI systems that surpass human intelligence and can solve complex problems.

Artificial General Intelligence (AGI)

AGI is the stage where machines achieve human-like intelligence, a precursor to ASI.

Compounding Progress

Compounding progress in AI refers to the exponential advancements expected as technology evolves.

Companies Mentioned in this Article

OpenAI

OpenAI is focused on developing advanced AI technologies, including AGI and ASI, and has made significant strides since its founding.

Y Combinator

Y Combinator is a startup accelerator that supports innovative companies, including those in the AI sector.

DeepMind

DeepMind is a leader in AI research, known for its work in developing advanced AI systems and competing with OpenAI.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 7month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 7month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 7month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 7month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics